Category: Clinical Considerations
Nature Patients recovering from COVID-19 commonly exhibit cognitive and brain alterations, yet the specific neuropathological mechanisms and risk factors underlying these alterations remain elusive. Given the significant global incidence of COVID-19, identifying factors that can distinguish individuals at risk of developing brain alterations is crucial for prioritizing follow-up care. Here, we report findings from a […]
Aug 21, 2024
NYT The treatment can help prevent mild or moderate cases of Covid-19 from becoming more severe. Here’s what to know. Most adults in the United States have one condition or another that makes them a candidate for Paxlovid, which can cut the risk of a severe case of Covid. Obesity, diabetes, depression, heart conditions and dozens […]
Aug 20, 2024
COVID-related loss of smell tied to changes in the brain
CIDRAP A new study of 73 adults recovering from COVID-19 finds that those who lost their sense of smell showed behavioral, functional, and structural brain changes. Researchers in Chile conducted cognitive screening, performance on a decision-making task, functional testing, and magnetic resonance imaging (MRI) results with 73 patients after mild to moderate COVID-19 infection and 27 COVID-naïve […]
Aug 20, 2024
Common Lab Tests Not Useful in Diagnosing Long COVID, Study Shows
MedPageToday None of 25 routine laboratory tests were clinically useful for diagnosing long COVID, despite some slight differences in results between patients with and without prior SARS-CoV-2 infection, according to an analysis of the RECOVER-Adult cohort. Among participants with a post-acute sequelae of COVID-19 (PASC) index of 12 points or higher, there were no meaningful […]
Aug 13, 2024
Paxlovid, Vitamin Supplements Show Promise With Long COVID
Medscape Paxlovid, an antiviral approved last year to treat acute infections of COVID-19, is showing great potential as a new treatment for long COVID and may be the most promising experimental therapy now being studied for treating the condition. New research offers strong evidence that Paxlovid provides significant benefits for COVID-19 patients who are at […]
Jul 30, 2024
What to Know About Long COVID and How to Reduce Your Risk
UCSF UCSF scientists are seeking to solve COVID-19’s greatest riddles with sophisticated imaging techniques that have found long-term immune activation throughout the body. UC San Francisco scientists have found that SARS-CoV-2 can linger in the body for years and could be driving a global epidemic in long COVID. They’re also exploring the surprising long-term risks […]
Jul 30, 2024
COVID May Affect Type 1 Diabetes in Kids, and Not in a Good Way
MedPageToday COVID-19 may accelerate progression of presymptomatic type 1 diabetes in youth, a German study suggested. Incidence of clinical type 1 diabetes nearly doubled after the pandemic started among 591 youth ages 1 to 16 known to have presymptomatic type 1 diabetes, Anette-Gabriele Ziegler, MD, of the Institute of Diabetes Research at Helmholtz Munich in […]
Jul 16, 2024
COVID-19 leads to long-term changes in the immune system, study shows
MSN In a study recently published in the renowned journal “Allergy”, a MedUni Vienna research team shows that COVID-19 leads to considerable long-term changes in the immune system, even in mild cases. The findings could help to better understand the long-term consequences of an infection with SARS-CoV-2. As part of the study, the team led […]
Jul 16, 2024
Study reveals new mechanisms behind severe COVID-19 in obese individuals without diabetes
Med News.Net Already at the beginning of the COVID-19 pandemic, a group of Brazilian researchers pioneered in showing why SARS-CoV-2 infection tends to be more severe in diabetic patients. Now, the same team based at the Institute of Biology of the State University of Campinas (IB-UNICAMP) has discovered one of the reasons why obese people […]
Jul 10, 2024
In-hospital delirium linked to long-term cognitive impairment in COVID-19 patients over 60
Medical News.Net In a recent study published in the JAMA Network Open, a group of researchers evaluated the association of in-hospital delirium (sudden, severe confusion and brain function changes) with functional disability and cognitive impairment (decline in memory and thinking skills) over the six months following discharge among older adults hospitalized with coronavirus disease 2019 (COVID-19). […]
Jul 10, 2024